These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5710084

  • 21. [Clinical and bacteriological problems of ethionamide therapy].
    Lányi M.
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):332-4. PubMed ID: 5897862
    [No Abstract] [Full Text] [Related]

  • 22. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M, Zachara A.
    Gruzlica; 1968 Jul; 37(1):31-8. PubMed ID: 5720035
    [No Abstract] [Full Text] [Related]

  • 23. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN, Barrera L.
    Medicina (B Aires); 2007 Jul; 67(3):231-7. PubMed ID: 17628909
    [Abstract] [Full Text] [Related]

  • 24. [Antitubercular agents].
    Eandi M, Buraglio M.
    Minerva Med; 1984 Mar 17; 75(11):555-9. PubMed ID: 6200803
    [Abstract] [Full Text] [Related]

  • 25. [Protionamide tolerance in patients with pulmonary tuberculosis showing poor tolerance to ethionamide].
    Utkin VV, Zankisova IG, Poleshchuk AK, Krylova NP, Gridneva SM.
    Vrach Delo; 1971 Nov 17; 11():79-81. PubMed ID: 5143287
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R, Verma SK, Sahai S, Kumar S, Jain A.
    Indian J Chest Dis Allied Sci; 2006 Nov 17; 48(3):183-6. PubMed ID: 18610675
    [Abstract] [Full Text] [Related]

  • 27. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA, Korotaev GA, Poleshchuk AK, Utkin VV, Golitsyna LV.
    Probl Tuberk; 1969 Nov 17; 47(1):27-33. PubMed ID: 5380204
    [No Abstract] [Full Text] [Related]

  • 28. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J.
    Gruzlica; 1966 Mar 17; 34(3):249-54. PubMed ID: 5947778
    [No Abstract] [Full Text] [Related]

  • 29. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M, Reutgen H, Iwainsky H.
    Z Tuberk Erkr Thoraxorg; 1965 Mar 17; 124(3):141-8. PubMed ID: 5899136
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [On the present status of chemotherapy of lung tuberculosis, especially in ambulatory use].
    Rink H.
    Z Tuberk Erkr Thoraxorg; 1967 Apr 17; 126(1):1-12. PubMed ID: 5631774
    [No Abstract] [Full Text] [Related]

  • 32. [Neuropsychiatric repercussions of antitubercular treatment with isoniazid, or isoniazid and ethionamide (apropos of 8 cases)].
    Bleandonu G, Boye J.
    Ann Med Psychol (Paris); 1969 Jul 17; 2(2):201-26. PubMed ID: 5385334
    [No Abstract] [Full Text] [Related]

  • 33. [Ethionamide in the treatment of young tuberculous children].
    Rachinskiĭ SV, Tatochenko VK, Mazurova MI.
    Probl Tuberk; 1971 Jul 17; 49(8):39-42. PubMed ID: 5317210
    [No Abstract] [Full Text] [Related]

  • 34. [Study of blood nicotinamide during anti-tuberculous treatment].
    Dumon JF, Lecourtois-Dumon T, Brouillet-Gabriel MT.
    Mars Med; 1970 Jul 17; 107(10):759-64. PubMed ID: 4248974
    [No Abstract] [Full Text] [Related]

  • 35. [Preliminary clinical experiments with thioamid of alpha-propyl-isonocotinic acid (Trevintix) in pulmonary tuberculosis].
    Owsiński J, Piotrowska E.
    Gruzlica; 1969 Apr 17; 37(4):309-14. PubMed ID: 4892237
    [No Abstract] [Full Text] [Related]

  • 36. [Ethionamide in the treatment of patients infected with drug resistant bacilli].
    Pregowski W, Zagórecka A.
    Pol Tyg Lek; 1966 May 30; 21(22):833-7. PubMed ID: 5962181
    [No Abstract] [Full Text] [Related]

  • 37. Ethionamide plus thiacetazone in pulmonary tuberculosis resistant to first-line drugs.
    Narang RK, Sarin JN.
    J Assoc Physicians India; 1966 Aug 30; 14(8):503-6. PubMed ID: 5914879
    [No Abstract] [Full Text] [Related]

  • 38. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H, Takahashi R, Nakai T, Torii R, Yo I.
    Iryo; 1966 Mar 30; 20(3):230-40. PubMed ID: 5964830
    [No Abstract] [Full Text] [Related]

  • 39. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S, Nosaki M, Iwasaki M, Hamano S, Furuya Y.
    Iryo; 1966 Mar 30; 20(3):251-6. PubMed ID: 5965119
    [No Abstract] [Full Text] [Related]

  • 40. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M, Izumi K, Kamima H, Hirose H, Saito M.
    Kekkaku; 1966 Jan 30; 41(1):39-46. PubMed ID: 5962711
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.